Standout Papers

Effects of Cotadutide on Metabolic and Hepatic Parameters in Adults With Overweight or Obesity and Type 2 Diabete... 2021 2026 2022 2024222
  1. Effects of Cotadutide on Metabolic and Hepatic Parameters in Adults With Overweight or Obesity and Type 2 Diabetes: A 54-Week Randomized Phase 2b Study (2021)
    Rajaa Nahra, Tao Wang et al. Diabetes Care

Immediate Impact

1 by Nobel laureates 7 from Science/Nature 72 standout
Sub-graph 1 of 20

Citing Papers

The Role of Pro-Inflammatory Cytokines in the Pathogenesis of Cardiovascular Disease
2024 Standout
A Phase 2 Randomized Trial of Survodutide in MASH and Fibrosis
2024 Standout
3 intermediate papers

Works of Phil Ambery being referenced

Effects of Cotadutide on Metabolic and Hepatic Parameters in Adults With Overweight or Obesity and Type 2 Diabetes: A 54-Week Randomized Phase 2b Study
2021 Standout
MEDI0382, a GLP-1 and glucagon receptor dual agonist, in obese or overweight patients with type 2 diabetes: a randomised, controlled, double-blind, ascending dose and phase 2a study
2018
and 4 more

Author Peers

Author Last Decade Papers Cites
Phil Ambery 856 438 387 54 1.3k
Antoine Makdissi 996 261 430 31 1.3k
Agostino Ognibene 691 373 397 61 1.6k
Daniel R. Quast 967 469 437 30 1.4k
Hiromasa Goto 609 430 223 34 1.1k
Michishige Terasaki 712 343 408 44 1.0k
Barbara Cresci 635 497 252 48 1.4k
Gianluca Bardini 982 476 418 39 1.5k
Vivian T. Thieu 807 439 306 44 1.6k
Helle Linnebjerg 1260 420 822 59 1.7k
Kunihiro Suzuki 650 493 344 55 1.5k

All Works

Loading papers...

Rankless by CCL
2026